Chelation therapy with desferrioxamine does not normalize ferritin level but attenuates oxidative damage and improves total antioxidant level in Malaysian Chinese beta-thalassaemia major patients
Beta-thalassaemia major causes severe anaemia and patients with it may be transfusion-dependent for life. Regular blood transfusions cause iron-overload that leads to oxidative damage which can hasten mortality. The objective of this research was to study the oxidant-antioxidant indices in beta-thal...
Saved in:
Main Authors: | Kuppusamy, U.R., Tan, J. |
---|---|
Format: | Article |
Language: | English |
Published: |
2011
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/3706/1/Chelation_therapy_with_Desferrioxamine_does_not_normalize_ferritin_level.pdf http://eprints.um.edu.my/3706/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Self-reported level of and factors influencing the compliance to desferrioxamine therapy in multitransfused thalassaemias
by: Lee, Way Seah, et al.
Published: (2011) -
Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment
by: Dahlui, M., et al.
Published: (2009) -
Correlation of oxidative stress with serum essential elements level in beta thalassaemia major patients in Sabah
by: Shazia Qaiser
Published: (2015) -
Deferasirox effectively removes cardiac iron in beta-thalassaemia patients with myocardial siderosis previously chelated with deferoxamine monotherapy or deferoxamine-deferiprone therapy
by: Pennell, D., et al.
Published: (2010) -
Correlation of Serum Erythropoietin and Ferritin Levels with the Frequency of Blood Donation
by: Uday Younis, Hussein, et al.